Morgan Stanley Hikes Zhipu Target 72% as China’s AI Price War Ends

Morgan Stanley has significantly raised its outlook on Chinese AI firm Zhipu, signaling an end to the industry's aggressive price wars. This shift toward profitability has sparked a 37% rally, highlighting a major sentiment pivot in the global AI landscape.
Morgan Stanley Hikes Zhipu Target 72% as China’s AI Price War Ends

Morgan Stanley has fundamentally shifted its stance on the Chinese AI sector, raising its price target for startup Zhipu by nearly 72%. This move triggered a massive five-day rally, with the company’s valuation surging over 37%. Analysts, led by Gary Yu, suggest that China’s AI industry is finally maturing, leaving behind a period of destructive price-cutting in favor of value-driven growth and sustainable monetization.

From a geopolitical perspective, this resurgence comes as Chinese firms navigate strict U.S. export controls on high-end semiconductors. Zhipu’s success suggests that domestic Chinese AI models are finding ways to remain competitive despite hardware limitations. For US-based investors, this indicates that the global AI race remains a multi-polar conflict, with Chinese software innovation potentially offsetting hardware bottlenecks imposed by Washington.

For the crypto and decentralized AI markets, this rally serves as a significant sentiment indicator. While Zhipu is a traditional equity, the health of major AI labs often dictates the risk appetite for decentralized compute and AI-agent protocols. The transition out of a 'price war' phase suggests higher margins across the stack, which could eventually trickle down into increased demand for decentralized infrastructure providers.

Investors should closely watch for potential spillover into AI-linked digital assets. If the 'value era' for Chinese AI persists, it may embolden global venture capital to rotate back into high-growth tech, providing a tailwind for the broader crypto-AI narrative. Key factors to monitor include upcoming Chinese regulatory clarity and any further updates to U.S. chip restrictions that could impact model training schedules.